New Surgical Technique Controls Prosthetic Joint Infections in Ninety Percent of Cases
A modified procedure combining vacuum wound sealing with direct antibiotic infusions controlled difficult prosthetic joint infections in about 90 percent of patients.
HEROIC BREAKING NEWS, written by our newsroom0 views
Bioengineer.org reported that a modified DAIR technique achieved infection control in about 90 percent of patients suffering from prosthetic joint infections. The retrospective case series evaluated 31 patients treated with the modified approach. [1]
Periprosthetic joint infection is a severe complication of hip and knee replacement surgery. Bioengineer.org reported that bacteria form dense biofilms on implanted prostheses, which shield them from antibiotics circulating in the bloodstream and can destroy the joint. [1]
The modified technique pairs standard surgical debridement with vacuum-assisted wound sealing and daily infusions of antibiotics directly into the joint cavity. Antibiotics are antimicrobial substances that kill or inhibit the growth of bacteria to treat infections. [1][3]
Finding effective treatments for joint infections remains critical. As HEROIC BREAKING NEWS reported earlier, an umbrella review of 53 systematic reviews found that pooled mortality reached 11.0 percent for hip prosthetic joint infections and 13.3 percent for knee infections. [5]
In short
- A retrospective study of 31 patients showed a modified DAIR technique achieved about 90 percent infection control.
- The procedure combines surgical debridement, vacuum-assisted wound sealing, and daily intra-articular antibiotic infusions.
- Biofilms on prosthetic implants shield bacteria from antibiotics in the bloodstream.
Sources
Every paragraph above points to the numbered items it rests on. Read the originals here.
- [1]New DVIA Technique Combines Wound Drainage and Joint Antibiotics for Prosthetic InfectionsBioengineer.org, 2h ago (the report this story comes from)
Background
- [2]Drainage on Wikipedia
- [3]Antibiotic on Wikipedia
- [4]Low Dose Clindamycin Shows High Success Rate for Joint Infections HEROIC BREAKING NEWS, 2d ago
- [5]Umbrella Review Maps Mortality Rates for Prosthetic Joint Infections HEROIC BREAKING NEWS, 1d ago
Our newsroom writes these reports with the help of software, from the 5 sources listed and nothing else, and checks them against those sources. Facts can still be wrong or move on; the originals are the record. Spotted a mistake? Write to daniel@monsterkong.com.
Related from HEROIC BREAKING NEWS
Earlier reports of ours on the same people and subjects.
- Low Dose Clindamycin Shows High Success Rate for Joint InfectionsHumanitarian Tech, 2d ago
- Umbrella Review Maps Mortality Rates for Prosthetic Joint InfectionsHumanitarian Tech, 1d ago
- Meduni Vienna surgical team develops technique for aortic valve replacementsHumanitarian Tech, 14d ago
- Engineers Test Real Time Acoustic Control for Prosthetic HandsHumanitarian Tech, 8d ago
- Fifteen minute procedure offers lasting carpal tunnel relief without surgeryMedical Breakthroughs, 7d ago
More in Humanitarian Tech
- St Clairsville Assistive Technology Expo Scheduled for November 54h ago
- MIT Researchers Use Magnetic Beads to Improve Prosthetic Control7h ago
- Rescue duck learns to walk with custom prosthetic feet8h ago
- Researchers develop low cost device to screen for blood disorders9h ago
- Injured Hornbill Recovers After Historic Beak Surgery in Netherlands22h ago
- University of Tulsa students apply artificial intelligence to prosthetic research23h ago
Get the day in one email
Reports like this one, the top news of the last 24 hours, every morning. Free, one email a day; readers can comment under every report.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.


Comments
Loading
Join the conversation
Comments are open to readers of our daily email: the top news of the last 24 hours, every morning, free. Sign up and the comment box opens.
Already on the list? Enter the same address and we will send a sign-in link.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.